Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin Prophylaxis in Stem Cell Transplant
NCT00398411Phase 3Completed
- Sponsor
- University of Cologne
- Start
- Oct 2006
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Bacteremia comparing Moxifloxacin with Placebo (2 arms). Primary endpoint: Incidence of Clinically Significant Bacteremia. Started Oct 2006; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Bacteremia
Beyond the preview
Go deeper on NCT00398411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398411.